Business Context and Reporting Period
Company: Ocular Therapeutix, Inc. (OCUL)
Filing Type: Form 8-K (Current Report)
Date of Report: March 12, 2020
Reporting Period: This filing serves as a notification that the Company announced its financial results for the quarter and year ended December 31, 2019, on March 20, 2020. The full details are contained in the press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. It references a press release (Exhibit 99.1) for the actual figures. Consequently, the following metrics are not available in this text:
- Revenue: Not provided in this text.
- Profit/Loss: Not provided in this text.
- Cash Flow: Not provided in this text.
- Margins: Not provided in this text.
- Debt and Liquidity: Not provided in this text.
Material Changes
The filing text does not provide specific comparative data or material changes versus prior periods. It only indicates that results for the period ended December 31, 2019, have been announced.
Guidance, Outlook, and Risks
Management Commentary: The filing states that the full text of the press release regarding the financial results is incorporated by reference as Exhibit 99.1.
Legal Disclaimer: The information in this Current Report, including Exhibit 99.1, is furnished to comply with Item 2.02 of Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor subject to the liabilities of that section, except as expressly set forth by specific reference in another filing.
Guidance and Risks: No specific guidance, outlook, risks, or contingencies are detailed in this text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 12, 2020) for the actual financial results for the quarter and year ended December 31, 2019.
- Verify the specific revenue, net loss, and cash position figures in the referenced press release, as they are absent from this cover document.
- Confirm the date of the financial results announcement (stated as March 20, 2020 in the text, though the press release is dated March 12, 2020).